Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked to provide a scientific opinion on a list of health claims pursuant to Article 13 of Regulation (EC) No 1924/2006. This opinion addresses the scientific substantiation of health claims in relation to calcium and potassium and maintenance of normal acid-base balance. The scientific substantiation is based on the information provided by the Member States in the consolidated list of Article 13 health claims and references that EFSA has received from Member States or directly from stakeholders. The food constituents that are the subject of the health claims are calcium and potassium. The Panel considers that calcium and potassium are sufficiently characterised. The claimed effects are “calcium contributes to acid/base balance within metabolism” and “mineral/potassium: key function within metabolism (intracellular cation)”. The target population is assumed to be the general population. In the context of the proposed wordings, the Panel assumes that the claimed effects refer to the maintenance of normal acid-base balance. The Panel considers that maintenance of normal acid-base balance is a beneficial physiological effect. The Panel notes that no evidence has been provided showing that the dietary intake of calcium and potassium affects normal acid-base balance in the general healthy population. The Panel concludes that a cause and effect relationship has not been established between the dietary intake of calcium and potassium and maintenance of normal acid-base balance.